Anna Spann is a highly skilled scientist specializing in quality control and cell therapy, currently serving as a Senior Scientist at Galapagos since 2024. Previously, they held multiple roles in quality control and research, including a Senior Quality Control Analyst position at KBI Biopharma and a Senior Research Associate at Bellicum Pharmaceuticals, Inc. Anna began their career at Merck Life Science, contributing significantly to the manufacturing of NextGen oligonucleotides. Their extensive experience also includes a tenure as an Epidemiology Investigator with Harris County Public Health.
This person is not in the org chart
This person is not in any teams
This person is not in any offices